Physician

Ryan Bruce Thorpe

According to 2025 Medicare claims, Ryan Thorpe (NPI: 1568880995) practices dermatology in the Boise City, ID market, with the plurality of this provider's patient population coming from Ada, ID. This provider's primary affiliated billing organization is ADA WEST DERMATOLOGY, PC (NPI: 1518973338; TIN: 20-3276415) and primary practice location at 83646-7128.

Thorpe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 636 traditional Medicare patients, billed 2,776 HCPCS/CPT codes, and received $582,005 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 354 prescription claims across 238 beneficiaries totaling $6,297 in drug costs, led by Doxycycline Monohydrate (Doxycycline Monohydrate). Open Payments data shows 46 records totaling $780. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $119,013 to $582,005. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,022 and ending at $6,297. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$291K$582K2019 Medicare payment: $119,013 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $344,652 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $405,414 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $501,139 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $553,611 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $582,005 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019168628$119,013
20204361,852$344,652
20215242,154$405,414
20225752,676$501,139
20236343,096$553,611
20246362,776$582,005

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$35K2015 Drug cost: $4,022 (USD; Tot_Drug_Cst)2016 Drug cost: $14,044 (USD; Tot_Drug_Cst)2017 Drug cost: $15,488 (USD; Tot_Drug_Cst)2018 Drug cost: $34,871 (USD; Tot_Drug_Cst)2019 Drug cost: $1,333 (USD; Tot_Drug_Cst)2020 Drug cost: $8,205 (USD; Tot_Drug_Cst)2021 Drug cost: $8,918 (USD; Tot_Drug_Cst)2022 Drug cost: $10,519 (USD; Tot_Drug_Cst)2023 Drug cost: $7,596 (USD; Tot_Drug_Cst)2024 Drug cost: $6,297 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153450$4,022
201659144$14,044
20174084$15,488
20182372$34,871
20192638$1,333
2020120204$8,205
2021158259$8,918
2022210334$10,519
2023219363$7,596
2024238354$6,297

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks423527$455
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks195305$320
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more146171$59
17000Destruction of precancer skin growth, 1 growth167220$35
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more142168$34

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Doxycycline MonohydrateDoxycycline Monohydrate66586$975
Clobetasol PropionateClobetasol Propionate18519$670
Triamcinolone AcetonideTriamcinolone Acetonide391,298$555
MupirocinMupirocin731,509$552
KetoconazoleKetoconazole351,070$534

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.46$780Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ryan Bruce Thorpe?

Tedicare shows public-source Medicare data for Ryan Bruce Thorpe (NPI 1568880995), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan Bruce Thorpe have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan Bruce Thorpe?

Ryan Bruce Thorpe is linked to ADA WEST DERMATOLOGY, PC (billing NPI 1518973338) in the available physician profile data.

Does Ryan Bruce Thorpe have Open Payments data?

Ryan Bruce Thorpe has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.